Amid Brexit Chaos, UK PM Promises More R&D Funding, Lower Taxes, And Other Pro-Innovation Measures
Executive Summary
The UK prime minister has promised more government R&D funding and other incentives in an attempt to reassure businesses worried by the uncertainty created by the Brexit vote. The move comes shortly before the Chancellor’s autumn statement and the next meeting of the UK EU Life Sciences Steering Group.
You may also be interested in...
UK Industry Welcomes R&D Measures In Chancellor’s Autumn Statement
Faced with a predicted sharp decline in economic growth as a result of the Brexit vote, the UK Chancellor of the Exchequer has fleshed out proposals for supporting R&D and innovation that have been welcomed by the biopharmaceutical industry.
Brexit Minister Says ‘No’ To UK Staying In EU Drug Regulatory Framework
Liam Fox, one of the ministers in charge of leading the UK out of the EU, does not want the country to stay within the wider European drug regulatory system, even though many in the life science sector see this as vital if regulatory divergence and drug marketing delays are to be avoided.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.